Federal Crackdown on Chinese hGH Leads to Huge Profits for Big Pharma

[Steroid News]

U.S.-based pharmaceutical companies who manufacture human growth hormone (hGH) have had record sales ever since the federal government cracked down on the import of hGH made by foreign manufacturers. An investigation by the Associated Press into performance-enhancing drugs (PEDs) discovered that sales of hGH increased by up to 69% from 2005 to 2012. In 2006,…
Read More

Read more: Federal Crackdown on Chinese hGH Leads to Huge Profits for Big Pharma